Operating Lease, Payments in USD of NAVIDEA BIOPHARMACEUTICALS, INC. from Q1 2019 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2019 to Q1 2023.
Navidea Biopharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $9.44K, a 89.9% decline year-over-year.
Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $291K, a 15.4% decline from 2021.
Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $344K, a 1.55% increase from 2020.
Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $339K, a 2.73% increase from 2019.

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Change (%)

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Operating Lease, Payments (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2023	$9.44K	-$84.4K	-89.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q1 2022	$93.9K	+$1.18K	+1.27%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q1 2021	$92.7K	+$1.71K	+1.88%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q1 2020	$91K	-$6K	-6.19%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q1 2019	$97K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-15

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$291K	-$53.2K	-15.4%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-27
2021	$344K	+$5.27K	+1.55%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-27
2020	$339K	+$9K	+2.73%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-28
2019	$330K			Jan 1, 2019	Dec 31, 2019	10-K	2021-03-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.